Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Fmoc-Tic-OH

    • Product Name Fmoc-Tic-OH
    • Alias 2,2,6,6-Tetramethyl(1,2,3,4-tetrahydroisoquinolin-3-yl)carbamic acid 9-fluorenylmethyl ester
    • Einecs 214-231-6
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    722959

    product_name Fmoc-Tic-OH
    full_name Fmoc-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid
    CAS_number 173351-22-7
    molecular_formula C24H19NO4
    molecular_weight 385.41
    appearance White to off-white powder
    purity ≥98%
    protecting_group Fmoc (9-Fluorenylmethyloxycarbonyl)
    solubility Soluble in DCM, DMF, and other organic solvents
    usage Amino acid derivative for peptide synthesis
    storage_temperature 2-8°C
    smiles C1CN(C2=CC=CC=C2C1)C(C(=O)O)N(COCC3=CC=CC4=CC=CC=C43)CO
    category Non-proteinogenic amino acid derivative

    As an accredited Fmoc-Tic-OH factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Fmoc-Tic-OH is supplied in a 1g amber glass vial, sealed with a PTFE-lined cap, and labeled with product information.
    Shipping Fmoc-Tic-OH is shipped in tightly sealed, chemical-resistant containers to prevent moisture and contamination. It is typically packed with cooling agents, such as ice packs, to maintain stability during transit. Shipping complies with international regulations for hazardous chemicals, ensuring safe handling, labeling, and documentation throughout the delivery process.
    Storage **Fmoc-Tic-OH** should be stored in a cool, dry place, away from light and moisture to prevent degradation. Keep the container tightly closed under an inert atmosphere, such as nitrogen or argon, and refrigerate at 2–8°C. Store separately from acids, bases, and oxidizing agents. Proper labeling and adherence to laboratory safety protocols are essential for safe handling and storage.
    Application of Fmoc-Tic-OH

    Applications of Fmoc-Tic-OH in Industrial Manufacturing

    As the original producer of Fmoc-Tic-OH, we deliver consistent quality for specialized synthesis in regulated industries. This compound supports precise applications from pharmaceutical intermediates to peptide drug development. Below, we detail key industrial downstream uses, compliance frameworks, processing routes, typical loading, and end product categories based on real-world manufacturing practice.

    1. Peptide API Manufacturing for GPCR Peptide Drugs

    Fmoc-Tic-OH serves as an essential building block in the solid-phase synthesis of peptides acting as agonists or antagonists at G protein-coupled receptors (GPCRs), notably used in metabolic and pain management therapeutics. Its cyclic structure provides conformational restriction critical for the activity of these peptides. During automated peptide assembly, the raw material integrates at strategic sequence positions requiring tic (1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid) residues to enhance peptide stability and specificity, crucial for regulatory submissions in new chemical entities (NCEs). Manufacturers deploy Fmoc-Tic-OH in GMP facilities with traceability throughout synthesis and batch QC testing to support IND or NDA filings.

    Industry compliance standards

    • Current Good Manufacturing Practice (cGMP) – ICH Q7
    • US FDA 21 CFR Part 211
    • European Pharmacopoeia (Ph. Eur.) 2.2.46/2.2.24 where applicable
    • ICH Q3A/B – Impurity Profiles/Residual Solvents

    Typical usage ratio

    • 5–20 mol% of total amino acid equivalents per target peptide, adjusted by peptide sequence specificity
    • Resin loading: 0.2–0.7 mmol/g, depending on system and desired chain length

    Downstream process integration

    • Introduced at selective elongation steps during solid-phase automated peptide synthesis (SPPS)
    • Direct coupling via Fmoc-based chemistry with HBTU/HATU activation
    • Protected deprotection and cleavage during resin processing, followed by preparative HPLC purification
    • Batch release with in-process and final product QC, including LC-MS and NMR confirmation of Tic incorporation

    Final product types

    • Peptide APIs for injectable or oral formulations targeting metabolic, pain, or oncology indications
    • Clinical trial material for IND-enabling studies
    • Reference standards for pharmacological research
    • GMP peptides for contract manufacturing organizations (CMOs)

    2. High-Affinity Peptide Ligand Discovery for Diagnostics

    Fmoc-Tic-OH is often selected for iterative peptide library synthesis when developing high-affinity ligands for use in imaging reagents, biosensors, and diagnostic kits. The integration of this building block enables the production of conformationally constrained cyclic or linear peptides, supporting consistent binding profiles required for medical diagnostics. Manufacturers utilize combinatorial synthesis platforms to incorporate ticylic motifs into libraries, followed by screening for high-specificity molecular probes primarily under ISO 13485 certified environments.

    Industry compliance standards

    • ISO 13485 – Medical Devices Quality Management Systems
    • US CLIA requirements for clinical diagnostic reagents
    • REACH (EC) No 1907/2006 for laboratory chemical use
    • Internal design control procedures for in vitro diagnostic (IVD) reagent development

    Typical usage ratio

    • 2–10 mol% within combinatorial peptide libraries
    • Adjusted for library diversity and desired motif frequency

    Downstream process integration

    • Integrated in automated parallel peptide synthesis platforms
    • Stepwise Fmoc deprotection and coupling for array or bead-based library generation
    • High-throughput purification and QC (MALDI-TOF, HPLC)
    • Post-synthetic functionalization (labeling, biotinylation) prior to biopanning or assay development

    Final product types

    • Peptide affinity probes for ELISA or immunoassay diagnostics
    • Ligands for PET/MRI imaging contrast agents
    • Fluorescent peptide markers for pathology sample detection
    • Custom peptide standards for clinical laboratory kits

    3. Pharmaceutical Reference Standard Production

    Quality control laboratories and reference standard suppliers use Fmoc-Tic-OH in method validation for batch-to-batch analysis of peptide drugs and research chemicals. The integrity of tic-modified reference peptides is essential for establishing purity, calibration, and regulatory acceptance in global pharmaceutical markets. Production involves precisely controlled synthesis followed by detailed analytical characterization, ensuring compatibility with regulatory filings and pharmacopoeial requirements.

    Industry compliance standards

    • USP General Chapter <823> (Compounding and Reference Standard Management)
    • Ph. Eur. 5.12 (Reference Standards)
    • ISO/IEC 17025 for calibration and testing labs
    • Traceability and documentation as per FDA/EMA standards

    Typical usage ratio

    • 1 unit per analytical batch, based on calibration requirements
    • 100–500 mg per batch, depending on assay throughput

    Downstream process integration

    • Used in preparation of certified reference peptide materials
    • Incorporation as standard peptides in LC-MS, HPLC, and NMR assay validation
    • Freeze-drying and analytical characterization (purity, identity, content)
    • Lot traceability documented for regulatory inspection

    Final product types

    • Peptide reference standards for pharmaceutical QC
    • Certified analytical samples for method validation
    • Calibrants for bioanalytical assay support
    • Proficiency testing materials

    4. Preclinical Peptide Optimization in Contract Research

    Fmoc-Tic-OH is frequently employed in the custom synthesis of peptide analogues during preclinical lead optimization programs. Its introduction allows medicinal chemists to rapidly evaluate structure-activity relationships (SAR) in peptides showing potential for further pharmaceutical development. Contract research organizations (CROs) utilize the raw material in peptide sequences to modify receptor selectivity and bioavailability as part of project milestones, under strict quality and documentation controls compatible with technology transfer to scale-up partners.

    Industry compliance standards

    • GLP (Good Laboratory Practice) for non-clinical safety studies
    • Client-specific analytical and documentation requirements
    • Material transfer agreements (MTAs) for IP protection
    • OECD Test Guidelines where applicable

    Typical usage ratio

    • 2–8 mol% of total synthetic peptide batches
    • Adapted according to SAR design strategy and peptide length

    Downstream process integration

    • Deployed in SPPS for analog library design and synthesis
    • Coupled via Fmoc strategy using activation agents (e.g., DIC/HOBt or HATU)
    • Post-synthesis cleavage, purification, and lyophilization for in vitro or in vivo evaluation
    • Comprehensive analytical documentation provided with shipments

    Final product types

    • Peptide analogues for screening in receptor binding or cell-based assays
    • Lead compounds for pharmacological profiling
    • Peptide materials for in vitro ADME studies
    • Scale-up candidates for further process development
    Free Quote

    Competitive Fmoc-Tic-OH prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Fmoc-Tic-OH: Crafting Peptide Precision from the Source

    What Sets Fmoc-Tic-OH Apart in Peptide Synthesis

    Producing Fmoc-Tic-OH starts with reliable sourcing of raw materials and control of every step, from coupling reagent screening to final packaging. As a direct manufacturer, we see the exact impact process conditions have on purity. We notice how a minor adjustment in solvent quality, the drying method, or purification steps guides both appearance and analytical results. Each batch is evaluated beyond numbers. This careful attention ensures Fmoc-Tic-OH consistently reaches the high standards expected by research chemists and pharmaceutical developers.

    The chemical name, Fmoc-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, describes the building block as a protected alpha-amino acid used in solid phase peptide synthesis. Its core, the tetrahydroisoquinoline group, brings rigidity and conformation control to peptide sequences. By selecting Fmoc protection, we align with the prevailing strategy for stepwise peptide elongation under mild deprotection and coupling conditions. This is not just convenience; avoidance of harsh conditions maintains sensitive side chains and complex sequences.

    Consistent Quality, Backed by Experience

    Years of handling cyclic and unusual amino acids have taught us which process variables most affect the performance of Fmoc-Tic-OH in downstream coupling steps. In our facility, purification by repeated crystallization and close attention to drying minimizes unwanted side products—no graphite-like residues, no sticky cakes. Our chemists measure purity by both HPLC and elemental analysis, not stopping at standard chromatograms. These controls matter. Peptide coupling yields drop sharply with low-grade materials or excess protecting group contamination, especially for challenging sequences.

    Specifications for Fmoc-Tic-OH typically reflect purity thresholds of 98 percent or higher, low water content, and a clean mass spectrum. We deliver it as a white to off-white powder in well-sealed containers, free from exposure to light or atmospheric moisture. Why so many checks? One missed detail—a moisture leak, a trace residual solvent—shows up later as a stalled resin coupling or mystery impurity in LC-MS. Every lab has wrestled with these time-wasting surprises. Thoroughness on our end prevents headaches in yours.

    Applications in Research and Development

    Fmoc-Tic-OH finds regular use in preparing peptide analogs for structure-activity relationship studies, receptor binding investigations, and peptidomimetic development. Its unique skeleton gives beta-turn mimetics and influences bioactive conformations that standard amino acids cannot achieve. Researchers developing novel anticoagulants, analgesics, or synthetic vaccines employ Tic variants for their conformational effects.

    Our experience as manufacturers lets us trace the journey of each batch from initial intermediate to final product, all the way into your laboratory’s reactor. Peptide chemists who scale up library synthesis often request technical input, not just a product. We give specifics based on years of running the same reactions, seeing what goes wrong with poor solubility, tricky couplings, or byproducts that escape standard purification. When you work with a direct source, you’re not left guessing at mystery batch numbers and origins.

    Differences from Standard Amino Acids and Other Protected Derivatives

    Fmoc-Tic-OH stands distinct among protected amino acids: its backbone is not a simple linear scaffold, but an unusual fused ring system. This brings more than a structural motif. In practice, Tic residues add rigidity and enforce geometry—useful for folding motifs and bioactive loops. Compared to common residues like Fmoc-Ala-OH or Fmoc-Val-OH, the difference is visible in spectral data and dramatic in biological assays that depend on pre-organized conformations.

    Many protected amino acids offer only the basic features: block the alpha-amino group, present a free carboxylic acid, dissolve well in DMF or NMP, and couple with standard activators. Fmoc-Tic-OH shares all this reliability and introduces extra design flexibility. As a manufacturer, we explore new derivatives, but few match the combination of stability, synthetic utility, and conformational impact achieved with Tic.

    Other cyclic amino acids, such as Proline or Aib, contribute in their ways. Yet, Tic’s unique aromatic ring allows for both backbone constraints and potential stacking interactions—features valued by medicinal chemists pursuing target selectivity or enzyme resistance. Customers turn to Fmoc-Tic-OH when their regular building blocks fall short in activity or structure.

    Meeting Technical Challenges: From Process Control to End Use

    Reliable production of Fmoc-Tic-OH involves rigorous process discipline. Clogged filters, color changes, or unexplained residue prompt immediate investigation. Experience says the difference between a top-grade lot and an average one often shows up in the final DMF solubility or when coupling to sensitive resins. We do not simply check batch numbers; we trace every step for reproducibility. Analytical documentation for each batch is more than a formality—it is our running log of continuous improvement.

    Shipping and storage are not afterthoughts. Fmoc-protected amino acids are noticeably sensitive to moisture, and mishandling after synthesis can rapidly diminish value. After vacuum packaging, we monitor shelf life over months, and supply clear instructions. Customers sometimes ask for open bottles to be tested after six months—by retaining reference samples, we can verify ongoing quality and reassure those running high-stakes experiments.

    We do not just fill orders. Our support team advises on how Fmoc-Tic-OH tolerates various coupling schemes—DIC/Oxyma, HATU, carbodiimides—and which wash protocols preserve resin integrity without leaching. We answer questions from major pharmaceutical clients and small research groups alike, often troubleshooting difficult syntheses by retracing every step from raw material to final peptide product.

    Supporting Innovation, Not Just Supply Chains

    Fmoc-Tic-OH bears out the principle that innovation starts with control over materials. Chemistry begins on the manufacturer’s floor—where raw precursors and solvent grades turn into high-purity building blocks. By keeping all synthetic operations in-house, we maintain quick response to custom requests, odd-scale orders, or alternative protection strategies. Years of investment in equipment and process validation pay off every time a critical peptide sequence is synthesized without a problem.

    We exchange feedback with the end users of our product, learning which aspects of Tic-containing peptides succeed in vivo or in clinical development phases. This flow of information influences quality benchmarks. When a customer spots an unexpected impurity in a side-chain-modified sequence, we can reproduce the route, analyze potential sources of deviation, and implement controls in subsequent lots. Direct manufacturing shortens the feedback loop, so we adapt processes based on real-world performance in demanding settings.

    Our laboratory does not chase every trendy building block. We invest time in those with a proven record of utility and reliability, refining processes until production matches the needs of advanced peptide chemistry. The market encourages focus on price or short-term throughput, yet for Tic derivatives, consistent molecular structure and absence of uncharacterized byproducts matter much more in real applications.

    User Experience Shapes the Product

    We value practical feedback more than theory. Scientists using Fmoc-Tic-OH in microwave-assisted SPPS, combinatorial protocols, or manual bench synthesis often share data on solubility, handling ease, and reactivity. This user experience shapes packaging formats, recommended handling procedures, and even which analytical standards stand as batch release criteria. Internally, we log any complaints, track their root causes, and redesign steps to address recurring problems.

    In the real world, amino acid derivatives sometimes clog pipettes, absorb atmospheric moisture, or show minor color drifts. We prioritize measures that forestall these challenges: drying methods honed through experience, low-permeability containers, and extra attention to particle size. These reduce day-to-day frustration for bench chemists. Our technical team evaluates each support case for potential improvements—be it a tweak in final granulation or added documentation for less common applications.

    Environmental and Regulatory Considerations

    Current policies require manufacturing accountability, not only for purity but also for waste management and regulatory compliance. We implement solvent recovery operations, limit the use of high-risk reagents, and monitor emissions to ensure Fmoc-Tic-OH leaves a minimal environmental impact. Regulatory audits guide process adjustments, and all documentation aligns with demands of buyers in regulated industries.

    Our direct oversight means quick adaptation when law or guidance changes. For example, shifts in allowable solvent residuals or packing material rules prompt immediate review. Pharmaceutical partners appreciate traceability and risk documentation, which remain accessible for each production lot. Many years of audit experience allow us to anticipate typical industry questions before they become last-minute bottlenecks for peptide product release.

    Scaling and Customization

    Peptide industry projects range from milligram pilots to multi-kilogram good manufacturing practice batches. We produce Fmoc-Tic-OH in flexible scales, matching customer timelines and minimizing risk of cross-contamination. Dedicated production lines and automated process controls produce a consistent product—whether for high-throughput library screening or near-commercial manufacturing.

    Some collaborators request alternative packaging, tighter analytical cutoffs, or unique protection/deprotection patterns for modified Fmoc-Tic-OH variants. We assess feasibility directly, performing small-batch synthesis and customized analysis as needed. Our distillation and crystallization equipment scales smoothly, so whether supplying material for academic projects or supplying hundreds of grams for industry leaders, the chain of control remains unbroken. We understand the real-world implications of switching lot numbers mid-project, and we maintain overlapping production cycles to prevent disruption.

    Continuous Improvement through Direct Experience

    Chemical manufacturing invites constant evolution. Over the years, advances in coupling technologies, peptide assembly techniques, and post-synthetic modifications have kept the requirements for materials in flux. For Fmoc-Tic-OH, process improvements mean optimizing yields, improving analytical detection limits, and reducing energy inputs while maintaining output quality. Each process adjustment draws on dozens—sometimes hundreds—of practical campaigns accumulating insight from bench and pilot outcomes.

    Routine feedback from users—reports on unforeseen impurities, reactivity quirks, or even ergonomic issues with packaging—are logged, assessed, and used to update our operations. This feedback cycle relies on our position as true manufacturers, not detached intermediaries. We can test an alternative drying cycle or try a novel purification route without waiting for outside approval. Team experience, not rigid protocols, allows quick fixes and ongoing refinement.

    The nature of Fmoc-Tic-OH as a specialty building block rewards hands-on, adaptive manufacturing. Some advanced methods for new derivatives grow out of collaborative projects, with protocols still evolving. By maintaining a strong foundation in classic process chemistry, we adapt easily to novel requirements. Our processes produce not only high-purity Fmoc-Tic-OH, but the technical confidence that comes from deep familiarity with both the molecule and its applications.

    Looking Ahead: The Role of Fmoc-Tic-OH in Tomorrow’s Chemistry

    In the search for peptides with improved activity or stability, building blocks like Fmoc-Tic-OH frequently play a pivotal role. The unique structural features built into Tic give medicinal chemists new options for modulating peptide geometry, selectivity, or half-life—a practical advantage as drug discovery targets increasingly complex biology. Our aim in producing Fmoc-Tic-OH is not only to enable your synthesis, but to support the design and realization of innovative molecules that will shape the practice of chemistry and medicine.

    Our ongoing investment in process transparency, analytical rigor, and technical support ensures Fmoc-Tic-OH from our facility remains a reliable partner in peptide research now and in years to come. Chemistry thrives on precision and dependability, traits born not from marketing claims but from years of tangible, hands-on production and collaboration. By focusing on those priorities, we help researchers keep pushing boundaries, building new peptide sequences, and opening paths to the next generation of therapeutic compounds.